# Autoimmune Hepatitis: A Review of Molecular Mechanisms and Research Gaps in African Populations

## TL;DR

This review discusses the molecular causes of autoimmune hepatitis and highlights the lack of research on African populations, which may experience a more severe form of the disease.

## Contribution

The paper emphasizes the need for more research on autoimmune hepatitis in African populations to address current knowledge gaps.

## Key findings

- Autoimmune hepatitis involves a complex interaction of genetics, environment, and immune dysfunction.
- Research on autoimmune hepatitis is heavily biased toward European populations, leaving African populations understudied.
- African ancestry populations may experience a more aggressive form of autoimmune hepatitis.

## Abstract

Autoimmune hepatitis is a liver disease where the body’s immune system attacks its own liver cells because it no longer recognises them, causing inflammation and damage that can eventually lead to liver failure. We do not fully understand the exact steps that cause autoimmune hepatitis, which makes it hard to figure out if a person has it and how best to treat it. This paper reviews what we currently know about how autoimmune hepatitis starts. It is a complicated mix of an individual’s genes, things they encounter in their environment, and the immune system. The review also looks at new technologies and models which scientists are using to figure out the precise biological details of the disease. Crucially, research on autoimmune hepatitis has focused almost entirely on people of European descent. This leaves a huge gap in our knowledge for other global groups, especially those of African ancestry, where evidence suggests they might experience a more severe form of the disease. Therefore, future research must focus on these underrepresented populations to develop tests and treatments that work well for everyone.

Autoimmune hepatitis (AIH) is an inflammatory liver disease characterised by immune-mediated hepatic injury, often leading to liver failure. The underlying molecular mechanisms of AIH remain poorly elucidated, hindering diagnostic and therapeutic advances. This review overviews the current understanding of AIH pathogenesis, which arises from a complex interplay of genetic predisposition, environmental triggers, and immune mechanisms (loss of tolerance, regulatory T cell dysfunction). Furthermore, current technologies and models which are being used to deconvolve the molecular profiles and pathophysiology of AIH are also discussed. Although AIH has a low reported global burden, AIH research is critically skewed towards European ancestry populations. This leaves a significant knowledge gap in diverse ancestry groups, such as those of African ancestry, where emerging research suggests that these patients may experience a more aggressive disease. Collectively, this highlights the need for research in underrepresented global populations to develop tailored diagnostics and effective targeted treatments.